DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS

DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS was reported 11573 times

DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEART SOUNDS 49 0.5104
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 138 0.2066
2 PROLONGED EXPIRATION 49 0.1870
3 LUPUS VULGARIS 227 0.1802
4 SEDATION COMPLICATION 435 0.1703
5 AMAUROSIS FUGAX 182 0.1690
6 SPIROMETRY ABNORMAL 72 0.1204
7 CREATININE RENAL CLEARANCE DECREASED 452 0.1128
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 226 0.1128
9 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 229 0.1104
10 MITE ALLERGY 72 0.1099
11 DISLOCATION OF VERTEBRA 250 0.1095
12 SERONEGATIVE ARTHRITIS 119 0.1038
13 RETINITIS 178 0.1029
14 PULMONARY VASCULITIS 54 0.1004
15 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 71 0.0890
16 MYCOTIC ALLERGY 73 0.0854
17 X-RAY ABNORMAL 149 0.0832
18 MULTIPLE DRUG THERAPY 62 0.0822
19 DUST ALLERGY 73 0.0744
20 ALVEOLAR OSTEITIS 31 0.0733
21 CREATININE RENAL CLEARANCE INCREASED 54 0.0722
22 GRIP STRENGTH 16 0.0699
23 PORPHYRIA ACUTE 99 0.0690
24 URINARY TRACT DISCOMFORT 31 0.0672
25 TOTAL LUNG CAPACITY ABNORMAL 26 0.0668
26 HYPOCHOLESTEROLAEMIA 23 0.0652
27 BODY TINEA 33 0.0589
28 SWOLLEN JOINT COUNT INCREASED 188 0.0589
29 RHEUMATIC FEVER 261 0.0585
30 DUODENAL ULCER PERFORATION 422 0.0567
31 MUSCLE INJURY 465 0.0561
32 SWOLLEN JOINT COUNT 14 0.0560
33 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 389 0.0542
34 BONE EROSION 191 0.0540
35 ADULTERATED PRODUCT 10 0.0500
36 BUNION OPERATION 28 0.0499
37 CONJUNCTIVITIS ALLERGIC 73 0.0493
38 FACET JOINT SYNDROME 158 0.0485
39 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 314 0.0483
40 HELICOBACTER INFECTION 490 0.0476
41 C-REACTIVE PROTEIN 42 0.0453
42 RHEUMATOID FACTOR POSITIVE 248 0.0429
43 FOLLICULITIS 419 0.0399
44 BLOOD CALCIUM DECREASED 445 0.0395
45 HAND DEFORMITY 505 0.0385
46 SUSPECTED SUICIDE 171 0.0365
47 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 26 0.0355
48 PEMPHIGUS 431 0.0344
49 URINARY TRACT DISORDER 153 0.0339
50 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 31 0.0334
51 NEURITIS 51 0.0330
52 BREAST CANCER STAGE III 211 0.0325
53 ANIMAL SCRATCH 31 0.0319
54 INCISION SITE PAIN 37 0.0315
55 EXPOSURE TO ALLERGEN 10 0.0313
56 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 17 0.0303
57 DRUG TOLERANCE DECREASED 82 0.0292
58 PERIPHERAL VENOUS DISEASE 119 0.0291
59 WOUND INFECTION 319 0.0291
60 ORTHOSTATIC HYPOTENSION 507 0.0291
61 HAEMORRHAGIC STROKE 227 0.0290
62 CAPILLARITIS 8 0.0290
63 HEPATIC ISCHAEMIA 9 0.0289
64 LABILE BLOOD PRESSURE 34 0.0286
65 INHIBITORY DRUG INTERACTION 45 0.0284
66 HYPERCHOLESTEROLAEMIA 273 0.0282
67 ANISOCORIA 10 0.0265
68 PERICARDITIS 438 0.0260
69 C-REACTIVE PROTEIN ABNORMAL 167 0.0260
70 JOINT RANGE OF MOTION DECREASED 347 0.0258
71 RHEUMATOID NODULE 71 0.0258
72 GRIP STRENGTH DECREASED 225 0.0255
73 SYNOVITIS 445 0.0247
74 NORMOCHROMIC NORMOCYTIC ANAEMIA 73 0.0243
75 RED BLOOD CELLS URINE POSITIVE 23 0.0238
76 IRRITABLE BOWEL SYNDROME 509 0.0237
77 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 48 0.0235
78 AUTOIMMUNE DISORDER 220 0.0225
79 GLOSSODYNIA 504 0.0225
80 JOINT DISLOCATION 237 0.0224
81 FOOT DEFORMITY 248 0.0224
82 DIAPHRAGMATIC DISORDER 17 0.0222
83 WALKING AID USER 140 0.0212
84 LUPUS-LIKE SYNDROME 188 0.0207
85 NODAL RHYTHM 30 0.0205
86 EXOSTOSIS 172 0.0188
87 IMPAIRED HEALING 615 0.0187
88 FORCED EXPIRATORY VOLUME DECREASED 53 0.0187
89 SPONDYLITIS 67 0.0184
90 ARTERIOVENOUS FISTULA 9 0.0183
91 RESPIRATORY SYMPTOM 52 0.0183
92 SEDATION 475 0.0181
93 BRASH SYNDROME 24 0.0171
94 RALES 99 0.0170
95 ALVEOLITIS 24 0.0170
96 LIP DRY 154 0.0169
97 TUNNEL VISION 31 0.0165
98 LOWER LIMB FRACTURE 316 0.0164
99 OCULAR DISCOMFORT 182 0.0162
100 PRESCRIBED OVERDOSE 305 0.0157
101 FIBROMYALGIA 381 0.0157
102 WOUND 437 0.0156
103 INFECTION SUSCEPTIBILITY INCREASED 34 0.0155
104 RENAL FUNCTION TEST ABNORMAL 69 0.0148
105 SCIATICA 234 0.0147
106 PULMONARY FIBROSIS 275 0.0143
107 PRESCRIBED UNDERDOSE 283 0.0142
108 DEPRESSIVE SYMPTOM 50 0.0142
109 RED BLOOD CELL SEDIMENTATION RATE INCREASED 154 0.0139
110 ARTERIOSCLEROSIS CORONARY ARTERY 92 0.0139
111 SINUS PAIN 32 0.0137
112 SPINAL FUSION SURGERY 55 0.0135
113 FULL BLOOD COUNT ABNORMAL 143 0.0135
114 GENERALISED OEDEMA 163 0.0132
115 PRINZMETAL ANGINA 13 0.0131
116 CONTRAINDICATED PRODUCT ADMINISTERED 391 0.0129
117 TYPE 2 DIABETES MELLITUS 434 0.0129
118 DEPRESSED LEVEL OF CONSCIOUSNESS 502 0.0127
119 OBSTRUCTIVE AIRWAYS DISORDER 139 0.0125
120 SYSTEMIC LUPUS ERYTHEMATOSUS 442 0.0124
121 EAR CONGESTION 33 0.0122
122 LIVE BIRTH 100 0.0119
123 BURSITIS 145 0.0119
124 HIP ARTHROPLASTY 181 0.0118
125 ULCER HAEMORRHAGE 79 0.0117
126 NODAL ARRHYTHMIA 10 0.0116
127 JOINT DESTRUCTION 18 0.0116
128 SICK SINUS SYNDROME 13 0.0113
129 LIVER INJURY 275 0.0112
130 HEPATIC CIRRHOSIS 210 0.0112
131 HEAD DISCOMFORT 194 0.0109
132 MATERNAL EXPOSURE TIMING UNSPECIFIED 41 0.0109
133 COGNITIVE DISORDER 507 0.0108
134 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 182 0.0107
135 POLYMYALGIA RHEUMATICA 34 0.0107
136 WOUND COMPLICATION 36 0.0105
137 BLADDER PAIN 33 0.0104
138 ALLERGY TO ANIMAL 11 0.0103
139 LOWER RESPIRATORY TRACT INFECTION 468 0.0103
140 MOBILITY DECREASED 739 0.0103
141 OBESITY 162 0.0102
142 PULMONARY ALVEOLAR HAEMORRHAGE 57 0.0102
143 NEUROLOGICAL SYMPTOM 57 0.0100
144 TENOSYNOVITIS 27 0.0098
145 SINUS ARREST 15 0.0096
146 ATRIOVENTRICULAR BLOCK COMPLETE 64 0.0096
147 EYE INJURY 29 0.0095
148 PARANASAL SINUS DISCOMFORT 36 0.0095
149 ALTERED STATE OF CONSCIOUSNESS 204 0.0094
150 HAEMATEMESIS 238 0.0094
151 BLISTER 513 0.0091
152 BRONCHIECTASIS 60 0.0089
153 ATRIOVENTRICULAR BLOCK SECOND DEGREE 27 0.0089
154 WHEEZING 524 0.0088
155 ABDOMINAL RIGIDITY 23 0.0085
156 PSORIATIC ARTHROPATHY 342 0.0084
157 JOINT STIFFNESS 221 0.0084
158 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 10 0.0083
159 MYOPATHY 71 0.0082
160 DELIRIUM 285 0.0082
161 WOUND SECRETION 32 0.0082
162 RESPIRATION ABNORMAL 56 0.0081
163 KNEE ARTHROPLASTY 171 0.0081
164 NERVE INJURY 90 0.0081
165 APPETITE DISORDER 53 0.0080
166 PHOTOPHOBIA 147 0.0078
167 PULMONARY CONGESTION 103 0.0078
168 HEPATORENAL SYNDROME 13 0.0077
169 DISCOMFORT 470 0.0077
170 ARTHROPATHY 426 0.0077
171 ARTERIOSCLEROSIS 72 0.0076
172 GAIT INABILITY 253 0.0076
173 INFUSION RELATED REACTION 499 0.0075
174 INJURY 519 0.0074
175 HEPATIC ENZYME INCREASED 497 0.0073
176 C-REACTIVE PROTEIN INCREASED 261 0.0072
177 BLOOD CHOLESTEROL INCREASED 334 0.0072
178 CALCULUS URINARY 11 0.0071
179 NASAL POLYPS 35 0.0071
180 OSTEOARTHRITIS 300 0.0071
181 PULMONARY FUNCTION TEST ABNORMAL 11 0.0071
182 INFUSION SITE REACTION 21 0.0070
183 MILIARIA 12 0.0070
184 DISABILITY 138 0.0070
185 PRESYNCOPE 169 0.0069
186 OEDEMA 374 0.0069
187 EAR INFECTION 183 0.0069
188 BALANCE DISORDER 591 0.0068
189 GINGIVAL RECESSION 13 0.0068
190 FOOT OPERATION 33 0.0067
191 STOMATITIS 399 0.0066
192 ASCITES 192 0.0065
193 DEATH NEONATAL 9 0.0065
194 GLUCOSE TOLERANCE IMPAIRED 38 0.0064
195 LIVER FUNCTION TEST INCREASED 136 0.0063
196 ANAL ABSCESS 34 0.0063
197 NIGHT SWEATS 203 0.0063
198 ATRIOVENTRICULAR BLOCK FIRST DEGREE 27 0.0062
199 PROTEIN URINE PRESENT 31 0.0062
200 HAEMATURIA 210 0.0061
201 VASOPLEGIA SYNDROME 10 0.0061
202 BRADYARRHYTHMIA 10 0.0061
203 ATRIOVENTRICULAR BLOCK 47 0.0061
204 BLEPHAROSPASM 38 0.0060
205 SLEEP DISORDER 424 0.0060
206 TOOTH INFECTION 79 0.0060
207 DIPLOPIA 154 0.0059
208 LOWER RESPIRATORY TRACT CONGESTION 10 0.0059
209 ROAD TRAFFIC ACCIDENT 245 0.0059
210 CARDIOGENIC SHOCK 84 0.0058
211 LUNG DISORDER 283 0.0058
212 PURPURA 51 0.0058
213 ANAL HAEMORRHAGE 16 0.0057
214 UPPER RESPIRATORY TRACT INFECTION 262 0.0057
215 CARDIO-RESPIRATORY ARREST 235 0.0056
216 COMPLETED SUICIDE 464 0.0056
217 DUODENAL ULCER 39 0.0055
218 DRUG-INDUCED LIVER INJURY 171 0.0054
219 FLANK PAIN 51 0.0054
220 NODULE 71 0.0054
221 BRADYCARDIA 288 0.0054
222 SINUS BRADYCARDIA 52 0.0054
223 CALCINOSIS 12 0.0054
224 SWELLING 502 0.0054
225 INFECTED SKIN ULCER 10 0.0053
226 TROPONIN INCREASED 40 0.0053
227 OSTEOPOROSIS 216 0.0052
228 ONYCHOMADESIS 22 0.0052
229 TORSADE DE POINTES 41 0.0052
230 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 251 0.0052
231 CONTUSION 502 0.0052
232 DERMATITIS EXFOLIATIVE 26 0.0052
233 THERAPEUTIC PRODUCT EFFECT DECREASED 229 0.0051
234 ASTHMA 574 0.0051
235 BLOOD IRON DECREASED 59 0.0050
236 PUSTULAR PSORIASIS 17 0.0049
237 SINUSITIS 500 0.0049
238 COMPLICATIONS OF TRANSPLANTED KIDNEY 11 0.0048
239 RESPIRATORY TRACT CONGESTION 77 0.0048
240 MUSCULOSKELETAL STIFFNESS 422 0.0048
241 HYPOXIA 168 0.0048
242 INTESTINAL ISCHAEMIA 26 0.0047
243 LIVER DISORDER 208 0.0047
244 BLINDNESS 190 0.0047
245 VENTRICULAR ARRHYTHMIA 17 0.0046
246 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 36 0.0046
247 TACHYCARDIA 411 0.0046
248 COMA 220 0.0046
249 JOINT SWELLING 557 0.0046
250 HYPERTRANSAMINASAEMIA 32 0.0046
251 BUNDLE BRANCH BLOCK RIGHT 21 0.0046
252 BUNDLE BRANCH BLOCK LEFT 19 0.0045
253 BILIARY COLIC 13 0.0045
254 BLOOD PRESSURE SYSTOLIC INCREASED 87 0.0045
255 ILL-DEFINED DISORDER 271 0.0045
256 MEDICATION ERROR 246 0.0044
257 NEUTROPHIL COUNT INCREASED 45 0.0044
258 TINNITUS 201 0.0044
259 THERAPY NON-RESPONDER 196 0.0044
260 BREAST CANCER STAGE I 40 0.0043
261 VASCULITIS 50 0.0043
262 EMBOLIC STROKE 15 0.0043
263 HUNGER 59 0.0042
264 MULTIPLE DRUG OVERDOSE 21 0.0042
265 KIDNEY INFECTION 83 0.0042
266 NAIL DISORDER 37 0.0042
267 RHEUMATOID ARTHRITIS 480 0.0042
268 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
269 ADRENAL INSUFFICIENCY 51 0.0042
270 HYPOTENSION 842 0.0042
271 HYPERLIPIDAEMIA 50 0.0042
272 AMNESIA 271 0.0042
273 INFECTION 600 0.0041
274 SKIN LACERATION 45 0.0041
275 ATRIAL FIBRILLATION 399 0.0041
276 TOXICITY TO VARIOUS AGENTS 689 0.0041
277 BLOOD PRESSURE SYSTOLIC ABNORMAL 10 0.0040
278 GENERAL PHYSICAL HEALTH DETERIORATION 467 0.0040
279 HYPERSENSITIVITY 748 0.0040
280 HYPOVENTILATION 13 0.0040
281 POLYARTHRITIS 21 0.0040
282 DISTRIBUTIVE SHOCK 9 0.0040
283 ANGINA PECTORIS 113 0.0039
284 PERIPHERAL SWELLING 603 0.0039
285 MUSCULOSKELETAL PAIN 203 0.0039
286 ONYCHOMYCOSIS 17 0.0039
287 BILIRUBIN CONJUGATED INCREASED 9 0.0038
288 EYE PAIN 216 0.0038
289 DRUG INTERACTION 602 0.0038
290 LYMPHOCYTE COUNT DECREASED 67 0.0038
291 DRUG INTOLERANCE 365 0.0038
292 FREQUENT BOWEL MOVEMENTS 102 0.0038
293 GASTROINTESTINAL DISORDER 338 0.0038
294 ANGIONEUROTIC OEDEMA 10 0.0037
295 MULTIPLE DRUG OVERDOSE INTENTIONAL 12 0.0037
296 WEIGHT FLUCTUATION 39 0.0037
297 OEDEMA PERIPHERAL 451 0.0037
298 SKIN WRINKLING 10 0.0037
299 BODY TEMPERATURE INCREASED 75 0.0037
300 BLOOD PRESSURE INADEQUATELY CONTROLLED 22 0.0037
301 GASTRITIS EROSIVE 17 0.0036
302 HYPOAESTHESIA 540 0.0036
303 TACHYARRHYTHMIA 9 0.0036
304 HYPERPARATHYROIDISM SECONDARY 9 0.0036
305 BLOOD UREA INCREASED 60 0.0036
306 NASOPHARYNGITIS 657 0.0036
307 PRODUCTIVE COUGH 169 0.0035
308 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
309 PREGNANCY 70 0.0035
310 INTRACRANIAL ANEURYSM 14 0.0035
311 CONFUSIONAL STATE 563 0.0035
312 INTENTIONAL PRODUCT USE ISSUE 302 0.0034
313 EAR PAIN 67 0.0034
314 HYPOVOLAEMIA 20 0.0034
315 BRONCHITIS 251 0.0034
316 TOOTH DISORDER 75 0.0034
317 MEDICATION RESIDUE PRESENT 16 0.0033
318 HYPERGLYCAEMIA 122 0.0033
319 HAEMODIALYSIS 28 0.0033
320 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 57 0.0033
321 BLADDER DISORDER 33 0.0033
322 BENIGN PROSTATIC HYPERPLASIA 17 0.0033
323 RECTAL HAEMORRHAGE 141 0.0033
324 PRODUCT LABEL CONFUSION 19 0.0033
325 INFLAMMATION 168 0.0033
326 MYOCARDIAL ISCHAEMIA 37 0.0032
327 MYOSITIS 29 0.0032
328 LEFT VENTRICULAR FAILURE 11 0.0032
329 FALL 1056 0.0032
330 AORTIC ARTERIOSCLEROSIS 8 0.0031
331 COMA SCALE ABNORMAL 9 0.0031
332 DIVERTICULUM 22 0.0031
333 DYSPNOEA EXERTIONAL 116 0.0031
334 BLOOD URINE PRESENT 58 0.0031
335 NEPHROLITHIASIS 140 0.0030
336 HYPERTHYROIDISM 44 0.0030
337 SYNCOPE 303 0.0030
338 BREAST CANCER STAGE II 25 0.0030
339 ABDOMINAL DISCOMFORT 504 0.0030
340 CONSTIPATION 654 0.0030
341 STAPHYLOCOCCAL BACTERAEMIA 13 0.0030
342 HYPOKINESIA 43 0.0030
343 WHITE BLOOD CELL COUNT INCREASED 113 0.0029
344 CHEST PAIN 545 0.0029
345 ACUTE HEPATIC FAILURE 40 0.0029
346 MUSCULAR WEAKNESS 332 0.0029
347 RHINITIS ALLERGIC 13 0.0029
348 ILEUS PARALYTIC 13 0.0029
349 DECREASED APPETITE 670 0.0029
350 HYPERKALAEMIA 101 0.0029
351 TOXIC SKIN ERUPTION 29 0.0029
352 RHABDOMYOLYSIS 119 0.0029
353 TREATMENT FAILURE 235 0.0028
354 DRY MOUTH 230 0.0028
355 NEPHROGENIC ANAEMIA 13 0.0028
356 HAEMOPTYSIS 78 0.0028
357 POISONING 35 0.0028
358 ATRIAL FLUTTER 22 0.0028
359 ACIDOSIS 21 0.0027
360 ORAL DISORDER 20 0.0027
361 SINUS DISORDER 54 0.0027
362 BLOOD CREATINE INCREASED 12 0.0027
363 SHOCK 62 0.0027
364 RASH VESICULAR 13 0.0027
365 HYPERTENSION 569 0.0027
366 ALOPECIA 525 0.0027
367 SUPRAVENTRICULAR EXTRASYSTOLES 9 0.0027
368 WEIGHT INCREASED 595 0.0027
369 BLOOD ALBUMIN DECREASED 21 0.0026
370 IMPAIRED QUALITY OF LIFE 38 0.0026
371 INSOMNIA 704 0.0026
372 DIFFICULTY IN WALKING 9 0.0026
373 ANGINA UNSTABLE 17 0.0026
374 INCREASED TENDENCY TO BRUISE 24 0.0026
375 RASH PRURITIC 141 0.0026
376 COLITIS ULCERATIVE 116 0.0026
377 BRAIN NATRIURETIC PEPTIDE INCREASED 8 0.0026
378 DERMATITIS EXFOLIATIVE GENERALISED 9 0.0026
379 FAECES HARD 10 0.0026
380 DRUG TOLERANCE 13 0.0026
381 TASTE DISORDER 52 0.0026
382 MUSCLE ATROPHY 32 0.0025
383 ARTHRITIS 197 0.0025
384 MATERNAL EXPOSURE DURING PREGNANCY 222 0.0025
385 CHILLS 290 0.0025
386 RASH MACULO-PAPULAR 55 0.0025
387 HYPOAESTHESIA ORAL 37 0.0025
388 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 174 0.0024
389 HYPOMAGNESAEMIA 34 0.0024
390 PYREXIA 844 0.0024
391 BLOOD PRESSURE DIASTOLIC DECREASED 18 0.0024
392 JOINT INJURY 52 0.0024
393 BLOOD CREATINE PHOSPHOKINASE INCREASED 70 0.0024
394 HAEMOGLOBIN INCREASED 11 0.0024
395 LUMBAR VERTEBRAL FRACTURE 11 0.0024
396 CORONARY ARTERY STENOSIS 12 0.0024
397 CONDITION AGGRAVATED 724 0.0024
398 CORONARY ARTERY DISEASE 72 0.0024
399 DYSPNOEA 1345 0.0024
400 RESPIRATORY DISORDER 71 0.0024
401 POOR QUALITY SLEEP 51 0.0024
402 DYSPEPSIA 233 0.0024
403 HEART RATE DECREASED 83 0.0024
404 SEPSIS 263 0.0024
405 VENTRICULAR FIBRILLATION 26 0.0023
406 EOSINOPHILIA 41 0.0023
407 HYPOTHYROIDISM 74 0.0023
408 ORAL HERPES 45 0.0023
409 BACK INJURY 25 0.0023
410 URTICARIA 383 0.0023
411 UNRESPONSIVE TO STIMULI 59 0.0023
412 ABDOMINAL PAIN UPPER 467 0.0023
413 PRURITUS 870 0.0023
414 OLIGURIA 14 0.0023
415 ENTEROCOLITIS 13 0.0022
416 PAIN IN EXTREMITY 661 0.0022
417 PRODUCT RESIDUE PRESENT 12 0.0022
418 GASTROOESOPHAGEAL REFLUX DISEASE 179 0.0022
419 ARTHRALGIA 921 0.0022
420 PHOTOPSIA 14 0.0022
421 SUSPECTED OFF LABEL USE 10 0.0022
422 LIMB INJURY 60 0.0022
423 PYELONEPHRITIS 19 0.0022
424 ASPIRATION 24 0.0022
425 BLOOD PRESSURE INCREASED 335 0.0022
426 WEIGHT DECREASED 609 0.0022
427 CIRCULATORY COLLAPSE 37 0.0022
428 WRIST FRACTURE 26 0.0022
429 EXTRASYSTOLES 15 0.0021
430 ANGIOPATHY 12 0.0021
431 UMBILICAL HERNIA 10 0.0021
432 BODY TEMPERATURE DECREASED 21 0.0021
433 VISUAL IMPAIRMENT 261 0.0021
434 CARDIAC TAMPONADE 10 0.0021
435 CHOLECYSTITIS 25 0.0021
436 HIATUS HERNIA 27 0.0021
437 KIDNEY TRANSPLANT REJECTION 10 0.0021
438 HYPOKALAEMIA 96 0.0021
439 TOOTH INJURY 9 0.0021
440 CELLULITIS 104 0.0021
441 IRON DEFICIENCY ANAEMIA 19 0.0021
442 GASTROINTESTINAL MOTILITY DISORDER 11 0.0021
443 DRUG LEVEL INCREASED 34 0.0021
444 FEELING OF BODY TEMPERATURE CHANGE 12 0.0020
445 PARAESTHESIA 320 0.0020
446 CHOLESTASIS 39 0.0020
447 VENTRICULAR EXTRASYSTOLES 21 0.0020
448 GAIT DISTURBANCE 386 0.0020
449 CEREBRAL ATROPHY 8 0.0020
450 CARDIAC ARREST 165 0.0020
451 THERAPEUTIC RESPONSE DECREASED 121 0.0020
452 HEPATITIS CHOLESTATIC 12 0.0020
453 SLEEP APNOEA SYNDROME 38 0.0020
454 POLYP 13 0.0020
455 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 10 0.0020
456 DRUG ERUPTION 35 0.0020
457 HEART RATE ABNORMAL 11 0.0020
458 MEMORY IMPAIRMENT 271 0.0020
459 PAIN 1211 0.0020
460 COUGH 551 0.0020
461 DECUBITUS ULCER 16 0.0020
462 ACUTE PULMONARY OEDEMA 11 0.0020
463 RENAL FAILURE ACUTE 83 0.0020
464 CARDIAC FAILURE ACUTE 13 0.0019
465 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 10 0.0019
466 RENAL FAILURE CHRONIC 15 0.0019
467 URINE OUTPUT DECREASED 17 0.0019
468 ADVERSE EVENT 177 0.0019
469 COAGULOPATHY 32 0.0019
470 BLOOD COUNT ABNORMAL 29 0.0019
471 EXERCISE TOLERANCE DECREASED 11 0.0019
472 FEELING HOT 117 0.0019
473 HYPONATRAEMIA 107 0.0019
474 BLOOD LACTIC ACID INCREASED 10 0.0019
475 ECCHYMOSIS 13 0.0019
476 SCRATCH 20 0.0019
477 CORONARY ARTERY OCCLUSION 26 0.0019
478 ANAL FISTULA 10 0.0019
479 CARDIOMEGALY 23 0.0019
480 MYALGIA 317 0.0019
481 PANCREATITIS 98 0.0019
482 HAEMOGLOBIN DECREASED 190 0.0018
483 EXPOSURE DURING PREGNANCY 115 0.0018
484 BLOOD POTASSIUM INCREASED 30 0.0018
485 DIVERTICULITIS 51 0.0018
486 PROTHROMBIN TIME PROLONGED 11 0.0018
487 DEMENTIA 51 0.0018
488 ERYTHEMA MULTIFORME 17 0.0018
489 DIABETIC NEUROPATHY 9 0.0018
490 FOOD ALLERGY 14 0.0018
491 RESPIRATORY ARREST 50 0.0018
492 ANEURYSM 9 0.0018
493 ELECTROLYTE IMBALANCE 21 0.0018
494 RESPIRATORY TRACT INFECTION 47 0.0018
495 DIZZINESS 899 0.0018
496 PROCEDURAL PAIN 50 0.0018
497 RESPIRATORY RATE INCREASED 16 0.0018
498 FEELING COLD 50 0.0018
499 SKIN FISSURES 35 0.0018
500 MUSCLE SPASTICITY 22 0.0018
501 RASH PUSTULAR 13 0.0018
502 ELECTROCARDIOGRAM ABNORMAL 14 0.0018
503 MUSCLE SPASMS 327 0.0018
504 INFUSION SITE ERYTHEMA 15 0.0018
505 MITRAL VALVE INCOMPETENCE 20 0.0018
506 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 92 0.0018
507 CARDIAC FAILURE 141 0.0018
508 HEART RATE INCREASED 173 0.0017
509 ABDOMINAL PAIN 406 0.0017
510 IMMUNODEFICIENCY 26 0.0017
511 PNEUMONIA BACTERIAL 16 0.0017
512 ANURIA 15 0.0017
513 PNEUMONIA 564 0.0017
514 CARDIAC MURMUR 15 0.0017
515 HEART RATE IRREGULAR 39 0.0017
516 LEUKOCYTOSIS 31 0.0017
517 DEPRESSION 389 0.0017
518 BLOOD LACTATE DEHYDROGENASE INCREASED 27 0.0017
519 RHINORRHOEA 110 0.0017
520 BRADYKINESIA 10 0.0017
521 ADVERSE DRUG REACTION 152 0.0017
522 HYPOALBUMINAEMIA 13 0.0017
523 DEPRESSED MOOD 88 0.0017
524 NORMAL NEWBORN 9 0.0017
525 MOVEMENT DISORDER 53 0.0016
526 INTERNATIONAL NORMALISED RATIO INCREASED 47 0.0016
527 PRODUCT USE IN UNAPPROVED INDICATION 408 0.0016
528 RENAL CYST 13 0.0016
529 VENTRICULAR TACHYCARDIA 27 0.0016
530 ASTHENIA 614 0.0016
531 RASH 711 0.0016
532 INFUSION SITE PAIN 21 0.0016
533 GASTRIC ULCER HAEMORRHAGE 9 0.0016
534 MULTIPLE ORGAN DYSFUNCTION SYNDROME 46 0.0016
535 OXYGEN SATURATION DECREASED 91 0.0016
536 PULMONARY OEDEMA 72 0.0016
537 HYDRONEPHROSIS 12 0.0016
538 BACK DISORDER 26 0.0016
539 IMPAIRED WORK ABILITY 34 0.0016
540 INFUSION SITE SWELLING 10 0.0016
541 TENDON PAIN 12 0.0016
542 SPINAL DISORDER 15 0.0016
543 HAEMODYNAMIC INSTABILITY 12 0.0016
544 MASS 22 0.0016
545 CHEST DISCOMFORT 161 0.0016
546 METABOLIC ACIDOSIS 50 0.0016
547 MALAISE 678 0.0015
548 SENSATION OF FOREIGN BODY 13 0.0015
549 EPILEPSY 47 0.0015
550 CATATONIA 8 0.0015
551 PSEUDOMONAS INFECTION 13 0.0015
552 ELECTROCARDIOGRAM QT PROLONGED 54 0.0015
553 PSORIASIS 195 0.0015
554 FATIGUE 1162 0.0015
555 GASTRIC HAEMORRHAGE 17 0.0015
556 ANOREXIA 19 0.0015
557 BLOOD TRIGLYCERIDES INCREASED 26 0.0015
558 GENERAL SYMPTOM 11 0.0015
559 DRUG ABUSE 122 0.0015
560 NASAL CONGESTION 86 0.0015
561 SUPRAVENTRICULAR TACHYCARDIA 14 0.0015
562 DYSARTHRIA 55 0.0015
563 VISION BLURRED 200 0.0015
564 SOMNOLENCE 293 0.0015
565 LIMB DISCOMFORT 45 0.0015
566 MIDDLE INSOMNIA 27 0.0014
567 MIGRAINE 138 0.0014
568 INFLUENZA 161 0.0014
569 HEADACHE 904 0.0014
570 UNDERDOSE 105 0.0014
571 ALANINE AMINOTRANSFERASE INCREASED 88 0.0014
572 COELIAC DISEASE 14 0.0014
573 BLOOD CREATININE INCREASED 93 0.0014
574 LABORATORY TEST ABNORMAL 42 0.0014
575 MUSCULOSKELETAL CHEST PAIN 22 0.0014
576 CONGENITAL ANOMALY 11 0.0014
577 INCONTINENCE 15 0.0014
578 BLOOD PRESSURE FLUCTUATION 34 0.0014
579 SEASONAL ALLERGY 20 0.0014
580 DIARRHOEA 912 0.0014
581 HERPES ZOSTER 81 0.0014
582 VOMITING 661 0.0014
583 INTERSTITIAL LUNG DISEASE 68 0.0014
584 DEVICE DISLOCATION 61 0.0014
585 NOCTURIA 17 0.0014
586 TACHYPNOEA 19 0.0014
587 CARDIAC FLUTTER 9 0.0014
588 CEREBRAL INFARCTION 34 0.0014
589 BLOOD MAGNESIUM DECREASED 12 0.0014
590 MULTI-ORGAN FAILURE 24 0.0014
591 DERMATITIS BULLOUS 10 0.0014
592 BRADYPHRENIA 9 0.0014
593 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
594 GASTRIC ULCER 26 0.0014
595 THROMBOSIS 110 0.0014
596 POLLAKIURIA 57 0.0014
597 DYSGRAPHIA 9 0.0014
598 SPINAL OSTEOARTHRITIS 12 0.0014
599 HAEMATOCRIT DECREASED 27 0.0014
600 ANXIETY 385 0.0014
601 LOWER GASTROINTESTINAL HAEMORRHAGE 10 0.0014
602 INJECTION SITE REACTION 93 0.0014
603 SHOCK HAEMORRHAGIC 11 0.0013
604 LEFT VENTRICULAR DYSFUNCTION 9 0.0013
605 BLOOD PRESSURE DECREASED 89 0.0013
606 TRANSFUSION 14 0.0013
607 OROPHARYNGEAL PAIN 123 0.0013
608 ACUTE CORONARY SYNDROME 11 0.0013
609 PEMPHIGOID 10 0.0013
610 SUDDEN DEATH 14 0.0013
611 EOSINOPHIL COUNT INCREASED 11 0.0013
612 PRODUCT USE ISSUE 247 0.0013
613 DISORIENTATION 52 0.0013
614 INTENTIONAL OVERDOSE 84 0.0013
615 ARRHYTHMIA 62 0.0013
616 INSURANCE ISSUE 20 0.0013
617 HYPOACUSIS 56 0.0013
618 PULMONARY EMBOLISM 123 0.0013
619 GASTRITIS 34 0.0013
620 SKIN DISORDER 43 0.0013
621 NECK PAIN 72 0.0013
622 CARPAL TUNNEL SYNDROME 18 0.0013
623 RIGHT VENTRICULAR FAILURE 9 0.0013
624 OESOPHAGITIS 14 0.0013
625 PNEUMONIA ASPIRATION 32 0.0013
626 SPUTUM DISCOLOURED 12 0.0013
627 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
628 TRICUSPID VALVE INCOMPETENCE 10 0.0013
629 MYOCLONUS 15 0.0013
630 HEPATIC CYTOLYSIS 16 0.0013
631 DYSURIA 46 0.0012
632 PARAESTHESIA ORAL 18 0.0012
633 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
634 ATELECTASIS 12 0.0012
635 PALPITATIONS 145 0.0012
636 ACCIDENTAL OVERDOSE 45 0.0012
637 MELAENA 27 0.0012
638 ACUTE KIDNEY INJURY 187 0.0012
639 POLYURIA 10 0.0012
640 BLOOD SODIUM DECREASED 23 0.0012
641 ABDOMINAL DISTENSION 127 0.0012
642 ARTHROPOD BITE 9 0.0012
643 RENAL FAILURE 160 0.0012
644 HEMIPLEGIA 10 0.0012
645 LEUKOPENIA 60 0.0012
646 GASTROINTESTINAL HAEMORRHAGE 100 0.0012
647 SUBDURAL HAEMATOMA 17 0.0012
648 THIRST 21 0.0012
649 BOWEL MOVEMENT IRREGULARITY 9 0.0012
650 ASPARTATE AMINOTRANSFERASE INCREASED 62 0.0012
651 RIB FRACTURE 24 0.0012
652 LUNG INFECTION 18 0.0012
653 EPISTAXIS 86 0.0011
654 MULTIPLE ALLERGIES 9 0.0011
655 SKIN HAEMORRHAGE 17 0.0011
656 INTERVERTEBRAL DISC PROTRUSION 25 0.0011
657 LACTIC ACIDOSIS 37 0.0011
658 BLOOD CALCIUM INCREASED 10 0.0011
659 SKIN EXFOLIATION 96 0.0011
660 DIZZINESS POSTURAL 11 0.0011
661 HEPATITIS 29 0.0011
662 HEPATIC FAILURE 34 0.0011
663 HEPATOTOXICITY 25 0.0011
664 BODY HEIGHT DECREASED 12 0.0011
665 BRONCHOSPASM 16 0.0011
666 CARDIAC FAILURE CONGESTIVE 90 0.0011
667 SENSORY LOSS 9 0.0011
668 BONE DENSITY DECREASED 35 0.0011
669 POST PROCEDURAL HAEMORRHAGE 13 0.0011
670 LOCALISED INFECTION 27 0.0011
671 MENTAL STATUS CHANGES 31 0.0011
672 GOUT 20 0.0011
673 MUSCLE DISORDER 9 0.0011
674 GASTROENTERITIS VIRAL 20 0.0011
675 RENAL IMPAIRMENT 93 0.0011
676 POST PROCEDURAL INFECTION 9 0.0011
677 BLOOD PRESSURE ABNORMAL 22 0.0011
678 NAUSEA 871 0.0011
679 PANIC ATTACK 40 0.0011
680 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
681 SPINAL COMPRESSION FRACTURE 9 0.0011
682 SUBARACHNOID HAEMORRHAGE 11 0.0011
683 PRODUCT DISTRIBUTION ISSUE 10 0.0011
684 HEPATIC FUNCTION ABNORMAL 40 0.0011
685 FACE OEDEMA 18 0.0011
686 TUBULOINTERSTITIAL NEPHRITIS 20 0.0011
687 BEDRIDDEN 14 0.0011
688 POOR VENOUS ACCESS 11 0.0011
689 LETHARGY 61 0.0011
690 ILLNESS 109 0.0011
691 BACK PAIN 245 0.0011
692 TOXIC EPIDERMAL NECROLYSIS 16 0.0011
693 MUSCLE TIGHTNESS 17 0.0010
694 RECALLED PRODUCT ADMINISTERED 10 0.0010
695 HAEMATOMA 27 0.0010
696 END STAGE RENAL DISEASE 19 0.0010
697 POST PROCEDURAL COMPLICATION 20 0.0010
698 PERICARDIAL EFFUSION 24 0.0010
699 RESPIRATORY FAILURE 75 0.0010
700 SWOLLEN TONGUE 32 0.0010
701 CATARACT 61 0.0010
702 HEPATIC STEATOSIS 19 0.0010
703 COVID-19 PNEUMONIA 12 0.0010
704 FAECES DISCOLOURED 22 0.0010
705 URINARY INCONTINENCE 30 0.0010
706 URINARY TRACT INFECTION 172 0.0010
707 FLUID RETENTION 51 0.0010
708 THROMBOCYTOPENIA 112 0.0010
709 PLATELET COUNT INCREASED 13 0.0010
710 DISSEMINATED INTRAVASCULAR COAGULATION 14 0.0010
711 PRODUCT ADMINISTRATION ERROR 20 0.0010
712 HYPERTENSIVE CRISIS 11 0.0010
713 ACUTE RESPIRATORY FAILURE 19 0.0010
714 TRANSIENT ISCHAEMIC ATTACK 33 0.0010
715 ENCEPHALOPATHY 24 0.0010
716 EYE HAEMORRHAGE 13 0.0010
717 PLEURAL EFFUSION 59 0.0010
718 EJECTION FRACTION DECREASED 15 0.0010
719 NEPHROPATHY 9 0.0010
720 PULMONARY HYPERTENSION 20 0.0010
721 GASTROENTERITIS 14 0.0010
722 SQUAMOUS CELL CARCINOMA 9 0.0010
723 DRUG TOXICITY 13 0.0010
724 DERMATITIS ALLERGIC 12 0.0010
725 DEVICE MALFUNCTION 67 0.0010
726 LOSS OF CONSCIOUSNESS 122 0.0010
727 GINGIVAL BLEEDING 13 0.0010
728 UPPER GASTROINTESTINAL HAEMORRHAGE 16 0.0010
729 HYPOGLYCAEMIA 46 0.0009
730 RENAL PAIN 10 0.0009
731 DRY EYE 47 0.0009
732 OFF LABEL USE 811 0.0009
733 INFLUENZA LIKE ILLNESS 76 0.0009
734 OVERDOSE 198 0.0009
735 HEPATOCELLULAR INJURY 13 0.0009
736 ACUTE MYOCARDIAL INFARCTION 27 0.0009
737 SKIN LESION 25 0.0009
738 INTENTIONAL DRUG MISUSE 19 0.0009
739 LYMPHOMA 14 0.0009
740 RESPIRATORY DISTRESS 25 0.0009
741 TENDONITIS 14 0.0009
742 HYPOCALCAEMIA 17 0.0009
743 BLOOD POTASSIUM DECREASED 27 0.0009
744 RESPIRATORY DEPRESSION 11 0.0009
745 EMPHYSEMA 9 0.0009
746 SKIN INFECTION 10 0.0009
747 HOT FLUSH 67 0.0009
748 ULCER 14 0.0009
749 CYSTITIS 28 0.0009
750 HERNIA 17 0.0009
751 EAR DISCOMFORT 9 0.0009
752 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 9 0.0009
753 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
754 DIABETES MELLITUS 66 0.0009
755 LIVER FUNCTION TEST ABNORMAL 25 0.0009
756 TREATMENT NONCOMPLIANCE 47 0.0009
757 ANGIOEDEMA 38 0.0009
758 RASH ERYTHEMATOUS 41 0.0009
759 MOUTH ULCERATION 18 0.0009
760 HEAD INJURY 27 0.0009
761 PRODUCT SUBSTITUTION ISSUE 49 0.0009
762 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
763 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
764 ANKLE FRACTURE 13 0.0008
765 PARALYSIS 12 0.0008
766 RASH MACULAR 29 0.0008
767 INTESTINAL OBSTRUCTION 31 0.0008
768 HAEMORRHOIDS 16 0.0008
769 PULMONARY MASS 12 0.0008
770 THINKING ABNORMAL 15 0.0008
771 ILEUS 10 0.0008
772 PERIPHERAL COLDNESS 11 0.0008
773 SWELLING FACE 52 0.0008
774 BURNING SENSATION 56 0.0008
775 ORAL DISCOMFORT 11 0.0008
776 FOOT FRACTURE 15 0.0008
777 MANIA 13 0.0008
778 VERTIGO 48 0.0008
779 HOSPITALISATION 121 0.0008
780 EYE IRRITATION 45 0.0008
781 FUNGAL INFECTION 26 0.0008
782 ANAEMIA 148 0.0008
783 ERUCTATION 15 0.0008
784 OSTEOMYELITIS 14 0.0008
785 DELUSION 12 0.0008
786 RED BLOOD CELL COUNT DECREASED 22 0.0008
787 PRODUCT DOSE OMISSION ISSUE 226 0.0008
788 SPINAL PAIN 9 0.0008
789 DERMATITIS 16 0.0008
790 AGEUSIA 19 0.0008
791 BACTERAEMIA 9 0.0008
792 DEHYDRATION 101 0.0008
793 PANCREATITIS ACUTE 17 0.0008
794 PRODUCT PRESCRIBING ERROR 18 0.0008
795 EYE SWELLING 28 0.0008
796 SPINAL FRACTURE 15 0.0007
797 SENSORY DISTURBANCE 12 0.0007
798 SPEECH DISORDER 39 0.0007
799 JAUNDICE 20 0.0007
800 SKIN CANCER 16 0.0007
801 FEMUR FRACTURE 23 0.0007
802 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 19 0.0007
803 COLON CANCER 11 0.0007
804 MUSCULOSKELETAL DISORDER 14 0.0007
805 SKIN ULCER 19 0.0007
806 CHOLELITHIASIS 24 0.0007
807 OSTEONECROSIS OF JAW 18 0.0007
808 FLATULENCE 41 0.0007
809 STEVENS-JOHNSON SYNDROME 16 0.0007
810 SECRETION DISCHARGE 9 0.0007
811 RASH PAPULAR 16 0.0007
812 HALLUCINATION, VISUAL 15 0.0007
813 HEMIPARESIS 12 0.0007
814 CARDIAC DISORDER 66 0.0007
815 DIALYSIS 10 0.0007
816 SINUS TACHYCARDIA 10 0.0007
817 BRAIN FOG 11 0.0007
818 MENTAL IMPAIRMENT 17 0.0007
819 CYANOSIS 11 0.0007
820 MYOCARDIAL INFARCTION 122 0.0007
821 GASTRIC DISORDER 24 0.0007
822 NEURALGIA 17 0.0007
823 LIP SWELLING 23 0.0007
824 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
825 HALLUCINATION 52 0.0007
826 BLOOD GLUCOSE INCREASED 130 0.0007
827 ECZEMA 36 0.0007
828 ORAL CANDIDIASIS 9 0.0007
829 HYPERHIDROSIS 88 0.0007
830 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
831 TREMOR 112 0.0007
832 SKIN DISCOLOURATION 31 0.0007
833 DYSPHAGIA 64 0.0007
834 PRODUCT TASTE ABNORMAL 9 0.0007
835 LACRIMATION INCREASED 20 0.0007
836 VIRAL INFECTION 22 0.0007
837 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 119 0.0007
838 ANAPHYLACTIC SHOCK 17 0.0007
839 HIP FRACTURE 21 0.0007
840 DEAFNESS 17 0.0006
841 ABASIA 16 0.0006
842 DYSKINESIA 26 0.0006
843 DRUG INEFFECTIVE 843 0.0006
844 MUSCULOSKELETAL DISCOMFORT 11 0.0006
845 PLATELET COUNT DECREASED 68 0.0006
846 PNEUMOTHORAX 10 0.0006
847 HALLUCINATION, AUDITORY 10 0.0006
848 BLOOD BILIRUBIN INCREASED 17 0.0006
849 PALLOR 17 0.0006
850 ERECTILE DYSFUNCTION 16 0.0006
851 RENAL DISORDER 29 0.0006
852 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
853 DYSGEUSIA 46 0.0006
854 EXPOSURE VIA SKIN CONTACT 16 0.0006
855 ABNORMAL DREAMS 17 0.0006
856 ANAPHYLACTIC REACTION 34 0.0006
857 PRODUCT AVAILABILITY ISSUE 14 0.0006
858 AGITATION 45 0.0006
859 CARDIOMYOPATHY 9 0.0006
860 NERVOUS SYSTEM DISORDER 19 0.0006
861 EYE DISORDER 20 0.0006
862 HAEMORRHAGE 63 0.0006
863 PAIN IN JAW 17 0.0006
864 INTENTIONAL DOSE OMISSION 17 0.0006
865 BLOOD GLUCOSE ABNORMAL 11 0.0006
866 INTENTIONAL SELF-INJURY 12 0.0006
867 NERVOUSNESS 31 0.0006
868 HYPERSOMNIA 17 0.0006
869 BACTERIAL INFECTION 11 0.0006
870 TRANSAMINASES INCREASED 13 0.0006
871 FRACTURE 11 0.0006
872 PARANOIA 10 0.0006
873 PROTEINURIA 11 0.0006
874 NEUROPATHY PERIPHERAL 55 0.0006
875 PHARMACEUTICAL PRODUCT COMPLAINT 15 0.0006
876 BASAL CELL CARCINOMA 9 0.0006
877 APHONIA 8 0.0006
878 PRODUCT USE COMPLAINT 9 0.0006
879 DRY SKIN 75 0.0006
880 ISCHAEMIC STROKE 10 0.0006
881 GALLBLADDER DISORDER 10 0.0006
882 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 13 0.0006
883 ERYTHEMA 114 0.0006
884 SEIZURE 64 0.0006
885 DYSSTASIA 16 0.0005
886 DYSPHONIA 32 0.0005
887 DISEASE RECURRENCE 26 0.0005
888 FULL BLOOD COUNT DECREASED 11 0.0005
889 SUICIDE ATTEMPT 33 0.0005
890 CONVULSION 31 0.0005
891 DIABETIC KETOACIDOSIS 13 0.0005
892 RASH GENERALISED 14 0.0005
893 URINARY RETENTION 18 0.0005
894 CONJUNCTIVITIS 10 0.0005
895 AGRANULOCYTOSIS 10 0.0005
896 ORAL PAIN 12 0.0005
897 CHROMATURIA 12 0.0005
898 SCAR 9 0.0005
899 HAEMATOCHEZIA 29 0.0005
900 FEELING JITTERY 10 0.0005
901 INCREASED APPETITE 10 0.0005
902 FEELING ABNORMAL 125 0.0005
903 BLOOD GLUCOSE DECREASED 25 0.0005
904 SEROTONIN SYNDROME 10 0.0005
905 RESTLESSNESS 19 0.0005
906 THROAT TIGHTNESS 14 0.0005
907 DYSTONIA 10 0.0005
908 NEUROTOXICITY 9 0.0005
909 CARDIOVASCULAR DISORDER 13 0.0005
910 CEREBROVASCULAR ACCIDENT 86 0.0005
911 COVID-19 89 0.0005
912 EYE PRURITUS 17 0.0005
913 SEPTIC SHOCK 22 0.0005
914 PRODUCT DISPENSING ERROR 11 0.0005
915 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
916 THROAT IRRITATION 22 0.0005
917 OSTEONECROSIS 16 0.0005
918 THERAPEUTIC RESPONSE SHORTENED 16 0.0005
919 LYMPHADENOPATHY 17 0.0005
920 INTENTIONAL PRODUCT MISUSE 42 0.0005
921 PNEUMONITIS 13 0.0005
922 ABDOMINAL PAIN LOWER 12 0.0005
923 CHRONIC KIDNEY DISEASE 36 0.0005
924 EATING DISORDER 10 0.0005
925 APHASIA 14 0.0005
926 FLUSHING 47 0.0005
927 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
928 STAPHYLOCOCCAL INFECTION 15 0.0005
929 GYNAECOMASTIA 14 0.0005
930 COLITIS 17 0.0004
931 INCORRECT DOSE ADMINISTERED 102 0.0004
932 BONE PAIN 26 0.0004
933 NEUTROPHIL COUNT DECREASED 18 0.0004
934 PRODUCT PREPARATION ERROR 9 0.0004
935 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
936 WHITE BLOOD CELL COUNT DECREASED 47 0.0004
937 DISTURBANCE IN ATTENTION 23 0.0004
938 OCULAR HYPERAEMIA 20 0.0004
939 NEOPLASM MALIGNANT 28 0.0004
940 CEREBRAL HAEMORRHAGE 15 0.0004
941 PANCYTOPENIA 23 0.0004
942 SURGERY 24 0.0004
943 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
944 AGGRESSION 20 0.0004
945 SKIN IRRITATION 18 0.0004
946 INJECTION SITE BRUISING 31 0.0004
947 DEEP VEIN THROMBOSIS 25 0.0004
948 PRODUCT QUALITY ISSUE 52 0.0004
949 IRRITABILITY 23 0.0004
950 DEATH 328 0.0004
951 NEUTROPENIA 50 0.0004
952 VISUAL ACUITY REDUCED 12 0.0004
953 MULTIPLE SCLEROSIS 17 0.0004
954 INJECTION SITE PAIN 109 0.0004
955 HYPOPHAGIA 9 0.0004
956 NIGHTMARE 12 0.0003
957 MUCOSAL INFLAMMATION 9 0.0003
958 DRUG DEPENDENCE 54 0.0003
959 PAIN OF SKIN 9 0.0003
960 CRYING 12 0.0003
961 DRUG ADMINISTRATION ERROR 10 0.0003
962 INJECTION SITE MASS 12 0.0003
963 THERAPY INTERRUPTED 23 0.0003
964 DRUG EFFECT DECREASED 17 0.0003
965 MOOD SWINGS 10 0.0003
966 INJECTION SITE PRURITUS 21 0.0003
967 PROSTATE CANCER 25 0.0003
968 APPLICATION SITE ERYTHEMA 8 0.0003
969 VAGINAL HAEMORRHAGE 13 0.0003
970 INJECTION SITE RASH 9 0.0003
971 INJECTION SITE SWELLING 22 0.0003
972 UNEVALUABLE EVENT 21 0.0003
973 MENTAL DISORDER 12 0.0003
974 SUICIDAL IDEATION 25 0.0003
975 EXTRA DOSE ADMINISTERED 11 0.0003
976 INJECTION SITE ERYTHEMA 33 0.0003
977 SKIN BURNING SENSATION 19 0.0003
978 ACCIDENTAL EXPOSURE TO PRODUCT 27 0.0003
979 FEBRILE NEUTROPENIA 17 0.0003
980 ABNORMAL BEHAVIOUR 10 0.0003
981 INJECTION SITE HAEMORRHAGE 20 0.0003
982 PRODUCT DOSE OMISSION 15 0.0002
983 MALIGNANT NEOPLASM PROGRESSION 23 0.0002
984 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
985 LUNG NEOPLASM MALIGNANT 9 0.0002
986 WITHDRAWAL SYNDROME 9 0.0002
987 DISEASE PROGRESSION 25 0.0002
988 DERMATITIS ATOPIC 11 0.0002
989 DEVICE LEAKAGE 9 0.0002
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 42 0.0002
991 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
992 NO ADVERSE EVENT 30 0.0002
993 DRUG DOSE OMISSION 24 0.0001
994 EMOTIONAL DISTRESS 17 0.0001
995 BREAST CANCER 11 0.0001